Sciencast Management LP acquired a new position in Nu Skin Enterprises, Inc. (NYSE:NUS) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 9,337 shares of the company’s stock, valued at approximately $420,000.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. State Street Corp lifted its stake in Nu Skin Enterprises by 7.6% during the first quarter. State Street Corp now owns 1,455,992 shares of the company’s stock valued at $31,813,000 after purchasing an additional 103,160 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Nu Skin Enterprises by 3.5% during the 1st quarter. Bank of New York Mellon Corp now owns 947,082 shares of the company’s stock worth $20,694,000 after acquiring an additional 31,622 shares in the last quarter. Norges Bank acquired a new position in shares of Nu Skin Enterprises in the 4th quarter worth $35,493,000. Deutsche Bank AG raised its position in shares of Nu Skin Enterprises by 1,773.4% during the first quarter. Deutsche Bank AG now owns 778,858 shares of the company’s stock worth $17,019,000 after purchasing an additional 737,284 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of Nu Skin Enterprises by 1.2% during the first quarter. Geode Capital Management LLC now owns 680,059 shares of the company’s stock valued at $14,859,000 after purchasing an additional 8,241 shares during the last quarter. Institutional investors and hedge funds own 73.06% of the company’s stock.
Several analysts have issued reports on the company. Tigress Financial restated a “buy” rating on shares of Nu Skin Enterprises in a report on Friday, May 29th. Jefferies Financial Group upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and boosted their price target for the company from $42.00 to $50.00 in a report on Thursday, July 2nd. Deutsche Bank raised their price objective on shares of Nu Skin Enterprises from $28.00 to $35.00 and gave the stock a “hold” rating in a research note on Thursday, May 7th. Citigroup reissued a “hold” rating and set a $41.00 target price on shares of Nu Skin Enterprises in a research note on Tuesday, July 7th. Finally, Stifel Nicolaus raised their target price on Nu Skin Enterprises from $35.00 to $36.00 and gave the stock a “hold” rating in a research report on Thursday, June 11th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $45.00.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.25 by $0.11. Nu Skin Enterprises had a return on equity of 17.91% and a net margin of 6.49%. The business had revenue of $518.03 million during the quarter, compared to analyst estimates of $477.01 million. During the same period last year, the company earned $0.77 earnings per share. Nu Skin Enterprises’s quarterly revenue was down 16.9% compared to the same quarter last year. Equities research analysts expect that Nu Skin Enterprises, Inc. will post 2.43 earnings per share for the current fiscal year.
In related news, insider Joseph Y. Chang sold 34,970 shares of the business’s stock in a transaction that occurred on Friday, June 5th. The stock was sold at an average price of $40.01, for a total value of $1,399,149.70. Following the completion of the sale, the insider now owns 37,882 shares of the company’s stock, valued at approximately $1,515,658.82. The sale was disclosed in a document filed with the SEC, which is available at this link. 3.40% of the stock is owned by company insiders.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Featured Story: What strategies should day traders use to execute a trade?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.